Literature DB >> 3689543

Evaluation of 3-mm diameter intravenous tubing for the rapid infusion of fluids.

G D Cross1.   

Abstract

The use of intravenous administration systems incorporating 3-mm internal diameter tubing is becoming more common in hospital practice. The maximum flow-rate of crystalloid solutions through 3-mm-diameter tubing is compared to that through conventional 4-mm tubing when connected to standard large-gauge intravenous cannulae. Lengths of intravenous tubing between 80 cm and 200 cm were tested in combination with 16 gauge, 14 gauge and 13 gauge intravenous cannulae. The results demonstrated that the use of 3-mm-diameter infusion sets, or the inclusion of even short lengths of 3-mm tubing in an infusion system, limits the maximum flow that can be delivered through a cannula of size 16 gauge or larger. The reduced performance of the 3-mm tubing makes administration systems incorporating even short lengths of this diameter of tubing unsuitable in emergency situations and locations where rapid infusion of fluids is vital.

Mesh:

Substances:

Year:  1987        PMID: 3689543      PMCID: PMC1285440          DOI: 10.1136/emj.4.3.173

Source DB:  PubMed          Journal:  Arch Emerg Med        ISSN: 0264-4924


  3 in total

1.  Use of a urologic set for improved fluid administration rates.

Authors:  S Nadeau; M Tousignant
Journal:  Can Anaesth Soc J       Date:  1985-05

2.  Effects of high infusion pressure and large-bore tubing on intravenous flow rates.

Authors:  J R Mateer; B M Thompson; J Tucker; C Aprahamian; J C Darin
Journal:  Am J Emerg Med       Date:  1985-05       Impact factor: 2.469

3.  Flow rate variance of commonly used IV infusion techniques.

Authors:  D J Dula; H A Muller; J W Donovan
Journal:  J Trauma       Date:  1981-06
  3 in total
  1 in total

1.  Translating resuscitation guidelines into practice: health care provider attitudes, preferences and beliefs regarding pediatric fluid resuscitation performance.

Authors:  Melissa J Parker; Asmaa Manan
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.